GlassScriptPhysician profile
Caroline P Ford
NPI 1043619414
$14,809.30
in general payments reported to CMS, 2019-2025
36 companies · $4,232 in 2025
The $4,232 reported for 2025 was more than what 99% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,349 · 2022: $2,472 · 2023: $3,142 · 2024: $3,615 · 2025: $4,232.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,798 · Travel and Lodging: $2,058 · Education: $132.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,797.94 |
| Travel and Lodging | $2,058.06 |
| Education | $132.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $2,475.14 | 2023-2025 | Inspire |
| Glaxosmithkline, LLC. | $2,276.87 | 2021-2025 | Trelegy Ellipta, Nucala, Arexvy |
| Astrazeneca Pharmaceuticals LP | $1,897.39 | 2021-2025 | Fasenra, Breztri, Airsupra |
| Insmed, INC. | $1,135.35 | 2021-2025 | Arikayce, Brinsupri |
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,018.29 | 2021-2025 | Ofev, Jascayd, Spiriva Respimat |
| Genzyme Corporation | $664.46 | 2021-2025 | |
| Regeneron Healthcare Solutions, INC. | $620.19 | 2021-2025 | Dupixent |
| Electromed, INC. | $568.49 | 2022-2025 | Smartvest |
| United Therapeutics Corporation | $453.55 | 2023-2025 | Tyvaso, Tyvaso |
| Harmony Biosciences LLC | $321.81 | 2022-2025 | Wakix |
| Baxter Healthcare | $300.88 | 2022-2025 | Hillrom - Vest System Model 105 Home Care |
| Merck Sharp & Dohme LLC | $291.53 | 2022-2025 | Zerbaxa, Dificid, Keytruda |
| Amgen INC. | $287.41 | 2022-2025 | Tezspire |
| Mylan Specialty L.P. | $282.82 | 2021-2024 | Yupelri |
| Actelion Pharmaceuticals US, INC. | $254.95 | 2021-2025 | Uptravi, Opsumit, Opsynvi |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Verona Pharma, INC. | $250.98 | 2025 | Ohtuvayre |
| Axsome Therapeutics, INC. | $238.27 | 2023 | Sunosi |
| Ani Pharmaceuticals, INC. | $223.17 | 2024-2025 | Purified Cortrophin Gel |
| Mallinckrodt Hospital Products INC. | $191.50 | 2021-2023 | Acthar |
| Takeda Pharmaceuticals U.S.A., INC. | $186.47 | 2021-2022 | |
| Sanofi-Aventis U.S. LLC | $132.23 | 2023 | |
| Philips North America LLC | $129.85 | 2021-2025 | Vest Therapy Und |
| Grifols USA, LLC | $127.92 | 2022-2024 | Prolastin-C Liquid, Xembify |
| Vifor Pharma, INC. | $95.26 | 2024 | Zemaira |
| Novartis Pharmaceuticals Corporation | $84.00 | 2022-2024 | |
| Jazz Pharmaceuticals INC. | $72.30 | 2023-2025 | |
| Resmed Corp | $57.45 | 2022-2025 | |
| Janssen Pharmaceuticals, INC | $36.46 | 2021-2022 | |
| Inogen, INC. | $21.11 | 2021 | |
| Pfizer INC. | $19.98 | 2024 | |
| Viatris Specialty LLC | $19.08 | 2025 | Yupelri |
| Avadel Cns Pharmaceuticals, LLC | $18.15 | 2025 | Lumryz |
| Medtronic, INC. | $16.06 | 2024 | Illumisite |
| Abbvie INC. | $14.14 | 2021 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $13.29 | 2024 | Lifevest |
| Olympus America INC. | $12.50 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Caroline Ford listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.